Skip to content

Clinical trials

Phase 2 Meibomian Gland Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Meibomian Gland Dysfunction Phase: Phase 2 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20132
20141
20181
20192
20202
20211
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Azura Ophthalmics3
Cloudbreak Therapeutics, LLC2
Tarsus Pharmaceuticals, Inc.2
Allergan1
AxeroVision, Inc.1
GIANCARLO FATOBENE1
Hovione Scientia Limited1
Kala Pharmaceuticals, Inc.1
ORA, Inc.1
Philadelphia Eye Associates1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Meibomian Gland Dysfunction15
Blepharitis3
Dry Eye Syndromes2
Graft vs Host Disease1
Mite Infestations1
Pain1
Stevens-Johnson Syndrome1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.